EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Zebrafish as a Model for Translational Immuno-Oncology

Gabriela Rodrigues Barbosa iD, Augusto Monteiro de Souza, Priscila Fernandes Silva iD, Caroline Santarosa Fávero, José Leonardo de Oliveira iD, Hernandes F Carvalho iD, Ana Carolina Luchiari, Leonardo O Reis iD

Journal of Personalized Medicine · 11.07.2025 · 15 (7) · 304

DOI: 10.3390/jpm15070304 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 11.07.2025. Verfasst von Gabriela Rodrigues Barbosa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Immuno-Oncology Institute, Pontifical Catholic University of Campinas, Campinas 13087-571, SP, Brazil. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, CNPq, Research Productivity, and INCT-UROGEN, National Council for Scientific and Technological Development, CNPq, Research Productivity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite remarkable progress in cancer immunotherapy, many agents that show efficacy in murine or in vitro models fail to translate clinically. Zebrafish (Danio rerio) have emerged as a powerful complementary model that addresses several limitations of traditional systems. Their optical transparency, genetic tractability, and conserved immune and oncogenic signaling pathways enable high-resolution, real-time imaging of tumor–immune interactions in vivo. Importantly, zebrafish offer a unique opportunity to study the core mechanisms of health and sickness, complementing other models and expanding our understanding of fundamental processes in vivo. This review provides an overview of zebrafish immune system development, highlighting tools for tracking innate and adaptive responses. We discuss their application in modeling immune evasion, checkpoint molecule expression, and tumor microenvironment dynamics using transgenic and xenograft approaches. Platforms for high-throughput drug screening and personalized therapy assessment using patient-derived xenografts (“zAvatars”) are evaluated, alongside limitations, such as temperature sensitivity, immature adaptive immunity in larvae, and interspecies differences in immune responses, tumor complexity, and pharmacokinetics. Emerging frontiers include humanized zebrafish, testing of next-generation immunotherapies, such as CAR T/CAR NK and novel checkpoint inhibitors (LAG-3, TIM-3, and TIGIT). We conclude by outlining the key challenges and future opportunities for integrating zebrafish into the immuno-oncology pipeline to accelerate clinical translation.

Schlagwörter

Stichwörter der Autor:innen

patient-derived xenografts (zAvatars)translational oncologyzebrafish

Autor:innen und Institutionen

  • Immuno-Oncology Institute, Pontifical Catholic University of Campinas, Campinas 13087-571, SP, Brazil.
  • UroGen, National Institute of Science, Technology and Innovation in Genitourinary Cancer (INCT), Campinas 13087-571, SP, Brazil.
  • UroScience, School of Medical Sciences, State University of Campinas, Campinas 13083-970, SP, Brazil.
  • Z-Safe, Fish Laboratory, Department of Physiology and Behavior, Biosciences Center, Federal University of Rio Grande do Norte, Natal 59078-970, RN, Brazil.
  • Department of Structural and Functional Biology, University of Campinas (UNICAMP), Campinas 13083-865, SP, Brazil.

ORCID-Profile: Gabriela Rodrigues Barbosa, Priscila Fernandes Silva, José Leonardo de Oliveira, Hernandes F Carvalho, Leonardo O Reis

Förderung

  • National Council for Scientific and Technological Development, CNPq, Research Productivity, and INCT-UROGEN
  • National Council for Scientific and Technological Development, CNPq, Research Productivity

Zitieren

APA

Barbosa, G. R., de Souza, A. M., Silva, P. F., Fávero, C. S., de Oliveira, J. L., Carvalho, H. F., Luchiari, A. C., & Reis, L. O. (2025). Zebrafish as a Model for Translational Immuno-Oncology. Journal of Personalized Medicine, 15(7), 304. https://doi.org/10.3390/jpm15070304

Vancouver

Barbosa GR, de Souza AM, Silva PF, Fávero CS, de Oliveira JL, Carvalho HF, et al. Zebrafish as a Model for Translational Immuno-Oncology. Journal of Personalized Medicine. 2025;15(7):304. doi:10.3390/jpm15070304

BibTeX
@article{Barbosa2025,
  author = {Barbosa, Gabriela Rodrigues and de Souza, Augusto Monteiro and Silva, Priscila Fernandes and Fávero, Caroline Santarosa and de Oliveira, José Leonardo and Carvalho, Hernandes F and Luchiari, Ana Carolina and Reis, Leonardo O},
  title = {Zebrafish as a Model for Translational Immuno-Oncology},
  journal = {Journal of Personalized Medicine},
  year = {2025},
  volume = {15},
  number = {7},
  pages = {304},
  doi = {10.3390/jpm15070304}
}
Kostenlos starten →